Scientists from the IOCB Prague, in collaboration with the Faculty of Tropical Agriculture of the Czech University of Agriculture in Prague, are solving the mystery of termite life.

Scientists from Dr. Lenka Maletinska's team have developed a new substance that may help to solve the health limitations of obesity and Alzheimer's disease.

Researchers from IOCB Prague, in collaboration with the University of Tübingen, and the Faculty of Science, Charles University, has developed a new type of contrast agent that can be used in both MRI and PET.

A research group led by Dr. Edward Curtis has developed two new types of catalytic DNA molecules (deoxyribozymes) that can reveal the presence of target molecules through fluorescence or color.

Technology from the laboratories of IOCB Prague has been given an extraordinary opportunity to succeed in the rapidly developing segment of gene therapy.

Pavel Hobza from the IOCB Prague and his team discovered improper hydrogen bond twenty years ago. Current discovery has the potential to simplify the previously adopted definition of the hydrogen bond.

A piece of software which enables researchers worldwide to speed up their work and helps them make scientific discoveries is expanding from science into commerce.

Researchers from IOCB Prague determined the first cryo-EM structures of a surface receptor of the human parasite T. brucei gambiense in complex with human complement factor C3 in different conformations.

Dr Petr Cígler and his collaborators are working on refining molecular systems for transporting ribonucleic acid (RNA) molecules into cells.

State-of-the-art laboratories have found their home at Harfa in Prague, where preclinical research will be conducted to bring promising molecules closer to the development of important medications.